CRISPR breakthroughs: New solutions for common diseases
Drug Discovery World
JULY 18, 2023
Nucleic acid-based diagnostics, which typically require PCR reagents and laboratory equipment, are crucial for identifying, treating, and preventing common infectious diseases. While type II (Cas9) is mainly used for gene-editing applications, CRISPR detecting tools primarily rely on type V (Cas12) and type VI (Cas13) collateral activity.
98 
Let's personalize your content